Skip to main content

Menopausal Syndrome

2
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

UNION therapeutics
UNION therapeuticsDenmark - Hellerup
1 program
1
estradiol plus MPAPhase 41 trial
Active Trials
NCT01698164Unknown1,200
Unimed Pharma
Unimed PharmaSlovakia - Bratislava
1 program
1
MELSMONPhase 31 trial
Active Trials
NCT01931748Completed104Est. Apr 2014
Life & Brain
Life & BrainGermany - Bonn
1 program
LuteinN/A1 trial
Active Trials
NCT07600567Not Yet Recruiting300Est. Apr 2027

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
UNION therapeuticsestradiol plus MPA
Unimed PharmaMELSMON
Life & BrainLutein

Clinical Trials (3)

Total enrollment: 1,604 patients across 3 trials

NCT01698164UNION therapeuticsestradiol plus MPA

Multi-centre Clinical Trial on Hormone Replacement Treatment in China

Start: Dec 20081,200 patients
Phase 4Unknown
NCT01931748Unimed PharmaMELSMON

A Randomized, Double-Blind, Parallel, Non-Inferiority, Multicenter Trial Evaluate the Efficacy and Safety of UNCNT Compared to MELSMON in Female With Menopausal Syndrome

Start: Apr 2013Est. completion: Apr 2014104 patients
Phase 3Completed
NCT07600567Life & BrainLutein

Algal Lutein Against Decline of Intellectual Nimbleness

Start: May 2026Est. completion: Apr 2027300 patients
N/ANot Yet Recruiting

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 late-stage (Phase 3) programs, potential near-term approvals
3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.